$2.34T
Total marketcap
$84.63B
Total volume
BTC 50.09%     ETH 15.35%
Dominance

Diaceutics DIUXF Stock

1.37 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
115.77M USD
LOW - HIGH [24H]
1.37 - 1.37 USD
VOLUME [24H]
17.75K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Diaceutics Price Chart

Diaceutics DIUXF Financial and Trading Overview

Diaceutics stock price 1.37 USD
Previous Close 1.12 USD
Open 1.12 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 1.12 - 1.12 USD
52 Week Range 1.12 - 1.38 USD
Volume 2K USD
Avg. Volume 0 USD
Market Cap 94.61M USD
Beta (5Y Monthly) 0.324964
PE Ratio (TTM) 112
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

DIUXF Valuation Measures

Enterprise Value 75.86M USD
Trailing P/E 112
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.8507533
Price/Book (mrq) 2.2178218
Enterprise Value/Revenue 3.89
Enterprise Value/EBITDA 36.544

Trading Information

Diaceutics Stock Price History

Beta (5Y Monthly) 0.324964
52-Week Change -18.86%
S&P500 52-Week Change 20.43%
52 Week High 1.38 USD
52 Week Low 1.12 USD
50-Day Moving Average 1.12 USD
200-Day Moving Average 1.12 USD

DIUXF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 84.47M
Float 46.53M
Short Ratio N/A
% Held by Insiders 46.78%
% Held by Institutions 47.41%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 3.71%
Operating Margin (ttm) 2.94%
Gross Margin 85.83%
EBITDA Margin 10.64%

Management Effectiveness

Return on Assets (ttm) 0.77%
Return on Equity (ttm) 1.74%

Income Statement

Revenue (ttm) 19.5M USD
Revenue Per Share (ttm) 0.23 USD
Quarterly Revenue Growth (yoy) 50.10%
Gross Profit (ttm) 16.74M USD
EBITDA 2.08M USD
Net Income Avi to Common (ttm) 724K USD
Diluted EPS (ttm) 0.01
Quarterly Earnings Growth (yoy) 66.40%

Balance Sheet

Total Cash (mrq) 19.84M USD
Total Cash Per Share (mrq) 0.24 USD
Total Debt (mrq) 1.33M USD
Total Debt/Equity (mrq) 3.13 USD
Current Ratio (mrq) 8.235
Book Value Per Share (mrq) 0.505

Cash Flow Statement

Operating Cash Flow (ttm) 5.1M USD
Levered Free Cash Flow (ttm) -354625 USD

Profile of Diaceutics

Country United States
State N/A
City Belfast
Address Building Two
ZIP BT9 6GW
Phone N/A
Website https://www.diaceutics.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 151

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Q&A For Diaceutics Stock

What is a current DIUXF stock price?

Diaceutics DIUXF stock price today per share is 1.37 USD.

How to purchase Diaceutics stock?

You can buy DIUXF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Diaceutics?

The stock symbol or ticker of Diaceutics is DIUXF.

Which industry does the Diaceutics company belong to?

The Diaceutics industry is Diagnostics & Research.

How many shares does Diaceutics have in circulation?

The max supply of Diaceutics shares is 84.68M.

What is Diaceutics Price to Earnings Ratio (PE Ratio)?

Diaceutics PE Ratio is now.

What was Diaceutics earnings per share over the trailing 12 months (TTM)?

Diaceutics EPS is 0 USD over the trailing 12 months.

Which sector does the Diaceutics company belong to?

The Diaceutics sector is Healthcare.